DOI QR코드

DOI QR Code

The Anti-calcification Effect of Dithiobispropionimidate, Carbodiimide and Ultraviolet Irradiation Cross-linking Compared to Glutaraldehyde in Rabbit Implantation Models

  • Park, Samina (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kim, Soo Hwan (Xenotransplantation Research Center, Seoul National University Hospital Biomedical Research Institute) ;
  • Lim, Hong-Gook (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Lim, Cheong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kim, Yong Jin (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2012.06.26
  • Accepted : 2012.08.31
  • Published : 2013.02.05

Abstract

Background: Glutaraldehyde (GA) is a widely used cross-linking agent for improving mechanical properties and resistance to enzymatic degradation of collagenous tissue, but it has several drawbacks such as calcification and cytotoxicity. The aim of this study was to find the alternative effective cross-linking methods to GA. Materials and Methods: Bovine pericardium was processed with GA with ethanol+octanol and glycine detoxification, and polyethylene glycol (PG) space filler, dimethyl 3,3'-dithiobispropionimidate (DTBP), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) treatment, and the physical fixation of ultraviolet irradiation were done. The biologic material properties of variously treated pericardial tissues were assessed by biochemical, mechanical and histological tests. Treated pericardial tissues were also implanted subcutaneously or intramuscularly into the rabbit for 10 weeks to assess the xenoreactive antibody response of immunoglobulin G and M, their anti-calcification effect. Results: The biochemical and mechanical properties of EDC fixed pericardial tissues were comparable to the GA fixed tissue. The cytotoxicity was lowest in space filler treated GA fixed group. In rabbit subcutaneous or intramuscular implantation models, decellularization, space filler, EDC treatment group showed significantly lower calcium content than GA only and DTBP treatment group (p<0.05, analysis of variance). The titer of anti $Gal{\alpha}1-3Gal{\beta}1$-4GlcNAc-R antibodies did not change in the postimplantation serial enzyme-linked immunosorbent assay. Hematoxylin and eosin and von Kossa staining showed that decellularization, space filler, EDC, and ultraviolet treatment had less inflammatory cell infiltration and calcium deposits. Conclusion: The decellularization process, PG filler, and EDC treatments are good alternative cross-linking methods compared to GA only fixation and primary amine of DTBP treatment for cardiovascular xenograft preservation in terms of the collagen cross-linking stability and in vivo anti-calcification effects.

Keywords

References

  1. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999;47:439-65. https://doi.org/10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
  2. Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-31. https://doi.org/10.1016/S0142-9612(00)00148-4
  3. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2011;32:3233-43. https://doi.org/10.1016/j.biomaterials.2011.01.057
  4. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-80. https://doi.org/10.1016/j.athoracsur.2004.06.033
  5. Lee C, Kim SH, Choi SH, Kim YJ. High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: in vitro material assessment and in vivo anticalcification effect. Eur J Cardiothorac Surg 2011;39:381-7. https://doi.org/10.1016/j.ejcts.2010.07.015
  6. Chang HW, Kim SH, Kim KH, Kim YJ. Combined anti-calcification treatment of bovine pericardium with amino compounds and solvents. Interact Cardiovasc Thorac Surg 2011; 12:903-7. https://doi.org/10.1510/icvts.2010.259747
  7. Vyavahare N, Hirsch D, Lerner E, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation: efficacy and mechanisms. Circulation 1997;95:479-88. https://doi.org/10.1161/01.CIR.95.2.479
  8. Oosthuysen A, Zilla PP, Human PA, Schmidt CA, Bezuidenhout D. Bioprosthetic tissue preservation by filling with a poly(acrylamide) hydrogel. Biomaterials 2006;27:2123-30. https://doi.org/10.1016/j.biomaterials.2005.10.008
  9. Charulatha V, Rajaram A. Dimethyl 3,3'-dithiobispropionimidate: a novel crosslinking reagent for collagen. J Biomed Mater Res 2001;54:122-8. https://doi.org/10.1002/1097-4636(200101)54:1<122::AID-JBM15>3.0.CO;2-N
  10. Adekogbe I, Ghanem A. Fabrication and characterization of DTBP-crosslinked chitosan scaffolds for skin tissue engineering. Biomaterials 2005;26:7241-50. https://doi.org/10.1016/j.biomaterials.2005.05.043
  11. Everaerts F, Torrianni M, van Luyn M, van Wachem P, Feijen J, Hendriks M. Reduced calcification of bioprostheses, cross-linked via an improved carbodiimide based method. Biomaterials 2004;25:5523-30. https://doi.org/10.1016/j.biomaterials.2003.12.054
  12. Olde Damink LH, Dijkstra PJ, van Luyn MJ, van Wachem PB, Nieuwenhuis P, Feijen J. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 1996;17:765-73. https://doi.org/10.1016/0142-9612(96)81413-X
  13. Pathak CP, Adams AK, Simpson T, Phillips RE Jr, Moore MA. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. J Biomed Mater Res A 2004;69:140-4.
  14. Valente M, Pettenazzo E, Thiene G, et al. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model. J Heart Valve Dis 1998;7:283-91.
  15. Stacchino C, Bona G, Bonetti F, Rinaldi S, Della Ciana L, Grignani A. Detoxification process for glutaraldehyde-treated bovine pericardium: biological, chemical and mechanical characterization. J Heart Valve Dis 1998;7:190-4.
  16. Wright GA, Faught JM, Olin JM. Assessing anticalcification treatments in bioprosthetic tissue by using the New Zealand rabbit intramuscular model. Comp Med 2009;59:266-71.
  17. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-66. https://doi.org/10.1002/jbm.820280602
  18. Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials 1994;15:465-9. https://doi.org/10.1016/0142-9612(94)90226-7
  19. Alcantar NA, Aydil ES, Israelachvili JN. Polyethylene glycol- coated biocompatible surfaces. J Biomed Mater Res 2000;51:343-51. https://doi.org/10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
  20. Vasudev SC, Chandy T. Polyethylene glycol-grafted bovine pericardium: a novel hybrid tissue resistant to calcification. J Mater Sci Mater Med 1999;10:121-8.
  21. Weadock KS, Miller EJ, Bellincampi LD, Zawadsky JP, Dunn MG. Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment. J Biomed Mater Res 1995;29:1373-9. https://doi.org/10.1002/jbm.820291108
  22. Weadock KS, Miller EJ, Keuffel EL, Dunn MG. Effect of physical crosslinking methods on collagen-fiber durability in proteolytic solutions. J Biomed Mater Res 1996;32:221-6. https://doi.org/10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M

Cited by

  1. In vivo efficacy for novel combined anticalcification treatment of glutaraldehyde-fixed cardiac xenograft using humanized mice vol.29, pp.7, 2013, https://doi.org/10.1177/0885328214552710
  2. Stiffness‐controlled three‐dimensional collagen scaffolds for differentiation of human Wharton's jelly mesenchymal stem cells into cardiac progenitor cells vol.104, pp.9, 2013, https://doi.org/10.1002/jbm.a.35762
  3. EDC Cross-linking of Decellularized Tissue: A Promising Approach? vol.23, pp.13, 2017, https://doi.org/10.1089/ten.tea.2016.0416
  4. Comparative analysis of methods for increasing the biostability of collagen films vol.8, pp.5, 2017, https://doi.org/10.1134/s2075113317050203
  5. Preparation and characterization of small-diameter decellularized scaffolds for vascular tissue engineering in an animal model vol.16, pp.None, 2013, https://doi.org/10.1186/s12938-017-0344-9
  6. Modern Approaches to Chemical Modification of Proteins in Biological Tissues: Consequences and Application vol.44, pp.1, 2013, https://doi.org/10.1134/s1068162018010144
  7. Chemical cross‐linking of xenopericardial biomeshes: A bottom‐up study of structural and functional correlations vol.26, pp.3, 2013, https://doi.org/10.1111/xen.12506
  8. Supercritical Carbon Dioxide-A Powerful Tool for Green Biomaterial Chemistry vol.13, pp.7, 2013, https://doi.org/10.1134/s1990793119070236
  9. Epoxy Chitosan-Crosslinked Acellular Bovine Pericardium with Improved Anti-calcification and Biological Properties vol.3, pp.4, 2020, https://doi.org/10.1021/acsabm.0c00067
  10. Mammalian Pericardium‐Based Bioprosthetic Materials in Xenotransplantation and Tissue Engineering vol.15, pp.8, 2013, https://doi.org/10.1002/biot.201900334
  11. Proanthocyanidin as a crosslinking agent for fibrin, collagen hydrogels and their composites with decellularized Wharton’s-jelly-extract for tissue engineering applications vol.35, pp.6, 2013, https://doi.org/10.1177/0883911520956252
  12. Biocompatiblibility analysis of the decellularized bovine pericardium vol.8, pp.2, 2020, https://doi.org/10.22494/cot.v8i2.110
  13. OPTIMIZED METHOD OF BOVINE PERICARDIUM DECELLULARIZATION FOR TISSUE ENGINEERING vol.74, pp.4, 2013, https://doi.org/10.36740/wlek202104101
  14. Decellularized xenografts in regenerative medicine: From processing to clinical application vol.28, pp.4, 2013, https://doi.org/10.1111/xen.12683